Abesamis, L.M.I.; Aliping, E.G.A.; Armada, F.K.G.H.; Danao, M.F.; del Valle, P.D.B.; Regencia, Z.J.G.; Baja, E.S.; Ligsay, A.D. In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1–4) Isolated from the Philippines. Vaccines 2022, 10, 1259. https://doi.org/10.3390/vaccines10081259
Abesamis, L.M.I.; Aliping, E.G.A.; Armada, F.K.G.H.; Danao, M.F.; del Valle, P.D.B.; Regencia, Z.J.G.; Baja, E.S.; Ligsay, A.D. In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1–4) Isolated from the Philippines. Vaccines 2022, 10, 1259. https://doi.org/10.3390/vaccines10081259
Abesamis, L.M.I.; Aliping, E.G.A.; Armada, F.K.G.H.; Danao, M.F.; del Valle, P.D.B.; Regencia, Z.J.G.; Baja, E.S.; Ligsay, A.D. In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1–4) Isolated from the Philippines. Vaccines 2022, 10, 1259. https://doi.org/10.3390/vaccines10081259
Abesamis, L.M.I.; Aliping, E.G.A.; Armada, F.K.G.H.; Danao, M.F.; del Valle, P.D.B.; Regencia, Z.J.G.; Baja, E.S.; Ligsay, A.D. In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1–4) Isolated from the Philippines. Vaccines 2022, 10, 1259. https://doi.org/10.3390/vaccines10081259
Abstract
Dengue is a viral mosquito-borne disease that rapidly spreads in tropical and subtropical countries, including the Philippines. One of its most distinguishing characteristics is the ability of the Dengue Virus (DENV) to easily surpass the innate responses of the body, thus activating B cells of the adaptive immunity to produce virus-specific antibodies. Moreover, Dengvaxia® is the only licensed vaccine for DENV, but recent studies showed that seronegative individuals become prone to increased disease severity and hospitalization. Owing to this limitation of the dengue vaccine, this study determined and compared consensus and unique B cell epitopes among each DENV (1-4) Philippine isolate to identify potential areas of interest for future vaccine studies and therapeutic developments. An in silico-based epitope prediction of forty (40) DENV 1-4 strains, each serotype represented by ten (10) sequences from The National Center for Biotechnology Information (NCBI), was conducted using Kolaskar and Tongaonkar antigenicity, Emini surface accessibility, and Parker hydrophilicity prediction in Immune Epitope Database (IEDB). Results showed that five (5) epitopes were consensus for DENV-1 with no detected unique epitope, one (1) consensus epitope for DENV-2 with two (2) unique epitopes, one (1) consensus epitope for DENV-3 plus two (2) unique epitopes, and two (2) consensus epitopes and one (1) unique epitope for DENV-4. The findings of this study would contribute to determining potential vaccine and diagnostic marker candidates for further research studies and immunological applications against DENV (1-4) Philippine isolates.
Keywords
Dengue; Epitope; Peptide; B cell; DENV-1; DENV-2; DENV-3; DENV-4; Vaccine
Subject
Biology and Life Sciences, Virology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
